CD8A and neoplasm: The human leucocyte antigen class I (HLA‐I) antigen presentation pathway, whereby peptides are presented for inspection by αβT cell receptors αβTCRs present on the surface of CD8+ T cells, is one of the core elements of the adaptive immune system and plays a crucial role in fighting intracellular pathogens and in the eradication of tumour cells [1].